five

DataSheet_1_The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China.docx

收藏
NIAID Data Ecosystem2026-03-14 收录
下载链接:
https://figshare.com/articles/dataset/DataSheet_1_The_effects_of_vaccination_on_the_disease_severity_and_factors_for_viral_clearance_and_hospitalization_in_Omicron-infected_patients_A_retrospective_observational_cohort_study_from_recent_regional_outbreaks_in_China_docx/21509703
下载链接
链接失效反馈
官方服务:
资源简介:
ObjectThis study attempted to explore the effects of vaccination on disease severity and the factors for viral clearance and hospitalization in omicron-infected patients. MethodsThe clinical manifestations of 3,265 Omicron-infected patients (BA.2 lineage variant; the Omicron group) were compared with those of 226 Delta-infected patients (the Delta group). A Multi-class logistic regression model was employed to analyze the impacts of vaccination doses and intervals on disease severity; a logistic regression model to evaluate the risk factors for hospitalization; R 4.1.2 data analysis to investigate the factors for time for nucleic acid negativization (NAN). ResultsCompared with the Delta group, the Omicron group reported a fast transmission, mild symptoms, and lower severity incidence, and a significant inverse correlation of vaccination dose with clinical severity (OR: 0.803, 95%CI: 0.742-0.868, p<0.001). Of the 7 or 5 categories of vaccination status, the risk of severity significantly decreased only at ≥21 days after three doses (OR: 0.618, 95% CI: 0.475-0.803, p<0.001; OR: 0.627, 95% CI: 0.482-0.815, p<0.001, respectively). The Omicron group also reported underlying illness as an independent factor for hospitalization, sore throat as a protective factor, and much shorter time for NAN [15 (12,19) vs. 16 (12,22), p<0.05]. NAN was associated positively with age, female gender, fever, cough, and disease severity, but negatively with vaccination doses. ConclusionBooster vaccination should be advocated for COVID-19 pandemic-related control and prevention policies and adequate precautions should be taken for patients with underlying conditions.

研究目的:本研究旨在探讨疫苗接种对奥密克戎(Omicron)感染者疾病严重程度的影响,以及奥密克戎感染患者的病毒清除与住院相关影响因素。 方法:纳入3265例奥密克戎BA.2亚型感染者作为奥密克戎组,226例德尔塔(Delta)感染者作为德尔塔组,对比两组患者的临床表现。采用多分类logistic回归模型分析疫苗接种剂次与间隔时间对疾病严重程度的影响;采用logistic回归模型评估患者住院的危险因素;使用R 4.1.2软件开展数据分析,探究核酸转阴时间(nucleic acid negativization, NAN)的影响因素。 结果:与德尔塔组相比,奥密克戎组传播速度更快、症状更轻微,严重程度发生率更低;疫苗接种剂次与临床严重程度呈显著负相关(OR=0.803,95%CI:0.742~0.868,p<0.001)。在7类及5类疫苗接种状态分层中,仅在接种3剂次后≥21天时,疾病严重程度风险显著降低(分别为OR=0.618,95%CI:0.475~0.803,p<0.001;OR=0.627,95%CI:0.482~0.815,p<0.001)。奥密克戎组中,基础疾病为患者住院的独立危险因素,咽痛为保护因素,且核酸转阴时间更短[15(12,19) vs 16(12,22),p<0.05]。核酸转阴时间与年龄、女性性别、发热、咳嗽及疾病严重程度呈正相关,与疫苗接种剂次呈负相关。 结论:应在新型冠状病毒肺炎(COVID-19)疫情防控政策中倡导加强针接种,并为存在基础疾病的患者采取充分的防护措施。
创建时间:
2022-11-07
二维码
社区交流群
二维码
科研交流群
商业服务